EV71: An emerging infectious disease vaccine target in the Far East?

Vaccine

Volumn 28, Issue 20, 2010, Pages 3516-3521

  Xu, Juan ^a,b   Qian, Yuan ^c   Wang, Shixia ^b,e   Serrano, Jill M Grimes ^e   Li, Wei ^d   Huang, Zuhu ^a,b   Lu, Shan ^a,b,e  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c CAPITAL INSTITUTE OF PEDIATRICS   (China)

^d Technology and Achievement Transformation Center of Taizhou Medical Hi Tech Zone   (China)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Emerging infectious disease; EV71; Hand, foot, and mouth disease; Vaccine development

Indexed keywords

ANTIBODY; BACTERIAL VECTOR; DNA VACCINE; EV71 VACCINE; INACTIVATED VACCINE; LIVE VACCINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 22A12; RECOMBINANT PROTEIN; RNA VACCINE; SYNTHETIC PEPTIDE; SYNTHETIC PEPTIDE SP55; SYNTHETIC PEPTIDE SP70; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE; VIRUS VACCINE; VIRUS VECTOR; VP1 DNA VACCINE; VP1 RECOMBINANT PROTEIN VACCINE;

ANTIBODY RESPONSE; ANTIGENICITY; ASIAN; BRAIN; CLINICAL RESEARCH; DEVELOPING COUNTRY; DISEASE SURVEILLANCE; DRUG DESIGN; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; ECHOCARDIOGRAPHY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; EPIDEMIC; FAR EAST; FLACCID PARALYSIS; HEART LEFT VENTRICLE FAILURE; HUMAN; IMMUNE RESPONSE; LUNG EDEMA; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY; VACCINATION; VIROLOGY; VIRUS ENCEPHALITIS; VIRUS LIKE AGENT; VIRUS MENINGITIS; VIRUS STRAIN;

ANIMALS; ANTIBODY FORMATION; ASIA; DISEASE MODELS, ANIMAL; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; HAND, FOOT AND MOUTH DISEASE; HUMANS; MOLECULAR EPIDEMIOLOGY; VACCINES, ATTENUATED; VACCINES, DNA; VACCINES, INACTIVATED; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 77950692185     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.03.003     Document Type: Review

References (85)

1. Hsiung G.D., and Wang J.R. Enterovirus infections with special reference to enterovirus 71. Journal of Microbiology, Immunology, and Infection [Wei Mian yu Gan Ran Za Zhi] 33 March (1) (2000) 1-8
2. Robinson C.R., Doane F.W., and Rhodes A.J. Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957; isolation of group A Coxsackie virus. Canadian Medical Association Journal 79 October (8) (1958) 615-621
3. Chang L.-Y., Tsao K.-C., Hsia S.-H., Shih S.-R., Huang C.-G., Chan W.-K., et al. Transmission and clinical features of enterovirus 71 infections in household contacts in Taiwan. JAMA 291 January (2) (2004) 222-227
4. McMinn P., Lindsay K., Perera D., Chan H.M., Chan K.P., and Cardosa M.J. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. Journal of Virology 75 August (16) (2001) 7732-7738
5. Cardosa M.J., Perera D., Brown B.A., Cheon D., Chan H.M., Chan K.P., et al. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerging Infection and Disorders 9 April (4) (2003) 461-468
6. Chan L.G., Parashar U.D., Lye M.S., Ong F.G., Zaki S.R., Alexander J.P., et al. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, Malaysia: clinical and pathological characteristics of the disease. Clinical Infections and Disorders 31 September (3) (2000) 678-683
7. Ranganathan S., Singh S., Poh C.L., and Chow V.T. The hand, foot and mouth disease virus capsid: sequence analysis and prediction of antigenic sites from homology modelling. Applied Bioinformatics 1 1 (2002) 43-52
8. Hendry E., Hatanaka H., Fry E., Smyth M., Tate J., Stanway G., et al. The crystal structure of coxsackievirus A9: new insights into the uncoating mechanisms of enteroviruses. Structure 7 December (12) (1999) 1527-1538
9. Brown B.A., and Pallansch M.A. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Research 39 December (2-3) (1995) 195-205
10. Rueckert R.R. Picornaviruses and their replication. In: Fields B.N.K.D. (Ed). Virology (1990), Lippincott-Raven, New York 507
11. Kung S.H., Wang S.F., Huang C.W., Hsu C.C., Liu H.F., and Yang J.Y. Genetic and antigenic analyses of enterovirus 71 isolates in Taiwan during 1998-2005. Clinical Microbiological Infections 13 August (8) (2007) 782-787
12. Caro V., Guillot S., Delpeyroux F., and Crainic R. Molecular strategy for 'serotyping' of human enteroviruses. The Journal of General Virology 82 January (Pt 1) (2001) 79-91
13. Brown B.A., Oberste M.S., Alexander Jr. J.P., Kennett M.L., and Pallansch M.A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. Journal of Virology 73 December (12) (1999) 9969-9975
14. Li C., Wang H., Shih S.R., Chen T.C., and Li M.L. The efficacy of viral capsid inhibitors in human enterovirus infection and associated diseases. Current Medicinal Chemistry 14 8 (2007) 847-856
15. Yeo W.M., and Chow V.T. The VP1 structural protein of enterovirus 71 interacts with human ornithine decarboxylase and gene trap ankyrin repeat. Microbial Pathogenesis 42 April (4) (2007) 129-137
16. Patel K.P., and Bergelson J.M. Foot and mouth: double trouble. Nature Medicine 15 7 (2009) 1-2
17. Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nature Medicine 15 July (7) (2009) 798-801
18. Nishimura Y., Shimojima M., Tano Y., Miyamura T., Wakita T., and Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nature Medicine 15 7 (2009 Jul) 794-797
19. Chua B.H., Phuektes P., Sanders S.A., Nicholls P.K., and McMinn P.C. The molecular basis of mouse adaptation by human enterovirus 71. The Journal of General Virology 89 July (Pt 7) (2008) 1622-1632
20. Chen T.C., Liu S.C., Huang P.N., Chang H.Y., Chern J.H., and Shih S.R. Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants. Journal of Biomedical Science 15 May (3) (2008) 291-300
21. Shih S.R., Tsai M.C., Tseng S.N., Won K.F., Shia K.S., Li W.T., et al. Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone. Antimicrobial Agents and Chemotherapy 48 September (9) (2004) 3523-3529
22. Tan C.S., and Cardosa M.J. High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1. Archives of Virology 152 6 (2007) 1069-1073
23. Sivasamugham L.A., Cardosa M.J., Tan W.S., and Yusoff K. Recombinant Newcastle Disease virus capsids displaying enterovirus 71 VP1 fragment induce a strong immune response in rabbits. Journal of Medical Virology 78 August (8) (2006) 1096-1104
24. Li X., Mao C., Ma S., Wang X., Sun Z., Yi Y., et al. Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides. Biochemical and Biophysical Research Communications 390 4 (2009) 1126-1128
25. Wu C.N., Lin Y.C., Fann C., Liao N.S., Shih S.R., and Ho M.S. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20 December (5-6) (2001) 895-904
26. Mateu M.G. Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Research 38 September (1) (1995) 1-24
27. Minor P.D. Antigenic structure of picornaviruses. Current Topics in Microbiology and Immunology 161 (1990) 121-154
28. Leitch E.C., Harvala H., Robertson I., Ubillos I., Templeton K., and Simmonds P. Direct identification of human enterovirus serotypes in cerebrospinal fluid by amplification and sequencing of the VP1 region. Journal of Clinical Virology 44 February (2) (2009) 119-124
29. Blomqvist S., Paananen A., Savolainen-Kopra C., Hovi T., and Roivainen M. Eight years of experience with molecular identification of human enteroviruses. Journal of Clinical Microbiology 46 July (7) (2008) 2410-2413
30. Iturriza-Gomara M., Megson B., and Gray J. Molecular detection and characterization of human enteroviruses directly from clinical samples using RT-PCR and DNA sequencing. Journal of Medical Virology 78 2 (2006 Feb) 243-253
31. Chen G.W., Hsiung C.A., Chyn J.L., Shih S.R., Wen C.C., and Chang I.S. Revealing molecular targets for enterovirus type 71 detection by profile hidden Markov models. Virus Genes 31 December (3) (2005) 337-347
32. Jee Y.M., Cheon D.S., Kim K., Cho J.H., Chung Y.S., Lee J., et al. Genetic analysis of the VP1 region of human enterovirus 71 strains isolated in Korea during 2000. Archives of Virology 148 September (9) (2003) 1735-1746
33. Singh S., Chow V.T., Chan K.P., Ling A.E., and Poh C.L. RT-PCR, nucleotide, amino acid and phylogenetic analyses of enterovirus type 71 strains from Asia. Journal of Virological Methods 88 August (2) (2000) 193-204
34. Shih S.R., Ho M.S., Lin K.H., Wu S.L., Chen Y.T., Wu C.N., et al. Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. Virus Research 68 July (2) (2000) 127-136
35. Shih S.R., Li Y.S., Chiou C.C., Suen P.C., Lin T.Y., Chang L.Y., et al. Expression of capsid [correction of caspid] protein VP1 for use as antigen for the diagnosis of enterovirus 71 infection. Journal of Medical Virology 61 June (2) (2000) 228-234
36. Oberste M.S., Maher K., Kilpatrick D.R., Flemister M.R., Brown B.A., and Pallansch M.A. Typing of human enteroviruses by partial sequencing of VP1. Journal of Clinical Microbiology 37 5 (1999 May) 1288-1293
37. Li L., He Y., Yang H., Zhu J., Xu X., Dong J., et al. Genetic Characteristics of Human Enterovirus 71 and Coxsackievirus A16 Circulating from 1999 to 2004 in Shenzhen, People's Republic of China. Journal of Clinical Microbiology 43 August (8) (2005) 3835-3839
38. McMinn P., Lindsay K., Perera D., Chan H.M., Chan K.P., and Cardosa M.J. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore and Western Australia. Journal of Virology 75 August (16) (2001) 7732-7738
39. Mizuta K., Abiko C., Murata T., Matsuzaki Y., Itagaki T., Sanjoh K., et al. Frequent Importation of Enterovirus 71 from Surrounding Countries into the Local Community of Yamagata, Japan, between 1998 and 2003. Journal of Clinical Microbiology 43 December (12) (2005) 6171-6175
40. Hiroyuki S., Andi U., Napa O., Chen L., Zhang L.-B., Ma Y.-J., et al. Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region. Pediatrics International 46 2 (2004) 231-235
41. Schmidt N.J., Lennette E.H., and Ho H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. The Journal of Infectious Diseases 129 3 (1974 Mar) 304-309
42. Kennett M.L., Birch C.J., Lewis F.A., Yung A.P., Locarnini S.A., and Gust I.D. Enterovirus type 71 infection in Melbourne. Bulletin of the World Health Organization 51 6 (1974) 609-615
43. Blomberg J., Lycke E., Ahlfors K., Johnsson T., Wolontis S., and von Zeipel G. Letter: New enterovirus type associated with epidemic of aseptic meningitis and -or hand, foot, and mouth disease. Lancet 2 July (7872) (1974) 112
44. Tagaya I., and Tachibana K. Epidemic of hand, foot and mouth disease in Japan, 1972-1973: difference in epidemiologic and virologic features from the previous one. Japanese Journal of Medical Science and Biology 28 August (4) (1975) 231-234
45. Chumakov M., Voroshilova M., Shindarov L., Lavrova I., Gracheva L., Koroleva G., et al. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Archives of Virology 60 3-4 (1979) 329-340
46. Nagy G., Takatsy S., Kukan E., Mihaly I., and Domok I. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Archives of Virology 71 3 (1982) 217-227
47. Samuda G.M., Chang W.K., Yeung C.Y., and Tang P.S. Monoplegia caused by Enterovirus 71: an outbreak in Hong Kong. The Pediatric Infectious Disease Journal 6 February (2) (1987) 206-208
48. Lum L.C., Wong K.T., Lam S.K., Chua K.B., and Goh A.Y. Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis. Lancet 352 October (9137) (1998) 1391
49. Lum L.C., Wong K.T., Lam S.K., Chua K.B., Goh A.Y., Lim W.L., et al. Fatal enterovirus 71 encephalomyelitis. The Journal of Pediatrics 133 December (6) (1998) 795-798
50. Bible J.M., Iturriza-Gomara M., Megson B., Brown D., Pantelidis P., Earl P., et al. Molecular epidemiology of Human Enterovirus 71 in the United Kingdom from 1998 to 2006. Journal of Clinical Microbiology 46 October (10) (2008) 3192-3200
51. Kehle J., Roth B., Metzger C., Pfitzner A., and Enders G. Molecular characterization of an enterovirus 71 causing neurological disease in Germany. Journal of Neurovirology 9 1 (2003) 126-128
52. Hagiwara A., Tagaya I., and Yoneyama T. Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection. Intervirology 9 1 (1978) 60-63
53. Huang C.C., Liu C.C., Chang Y.C., Chen C.Y., Wang S.T., and Yeh T.F. Neurologic complications in children with enterovirus 71 infection. The New England Journal of Medicine 341 September (13) (1999) 936-942
54. Chu P.Y., Lin K.H., Hwang K.P., Chou L.C., Wang C.F., Shih S.R., et al. Molecular epidemiology of enterovirus 71 in Taiwan. Archives of Virology 146 3 (2001) 589-600
55. Wang S.M., Liu C.C., Tseng H.W., Wang J.R., Huang C.C., Chen Y.J., et al. Clinical spectrum of enterovirus infection in children in southern Taiwan, with an emphasis on neurological complications. Clinical Infectious Diseases 29 1 (1999) 184-190
56. Herrero L.J., Lee C.S.M., Hurrelbrink R.J., Chua B.H., Chua K.B., and McMinn P.C. Molecular epidemiology of enterovirus 71 in peninsular Malaysia, 1997-2000. Archives of Virology 148 7 (2003) 1369-1385
57. Yang F., Ren L., Xiong Z., Li J., Xiao Y., Zhao R., et al. Enterovirus 71 outbreak in the People's Republic of China in 2008. Journal of clinical Microbiology 47 July (7) (2009) 2351-2352
58. Zhu R., Quian Y., Deng J., ZXing J., Zhao L., Wang F., et al. Study on the association of hand, foot and mouth disease and enterovirus 71/CA16 among children in Beijing, 2007. Chinese Journal of Epidemiology 28 10 (2007) 1004-1008
59. Deng J., Zhu R., Qian Y., Sun Y., Deng L., Huang R., et al. Etiology study on hand, foot and mouth disease in children in Beijing during 2007 to 2008. Chinese Journal of Laboratory Medicine 32 10 (2009)
60. Zhao H., Zhang Y., Zhang Y., Deng J., Zhu R., and Qian Y. Etiology and clinical characteristics of the 2007 outbreak of hand-foot-mouth disease in children in Beijing. Journal of Clinical Pediatrics 26 6 (2008) 467-469
61. Li Y., Zhu R., Qian Y., Deng J., Sun Y., Wang F., et al. Sequence analysis for VP4 of enterovirus 71 isolated in Beijing during 2007 to 2008. Journal of Microbes and Infection 4 1 (2009) 16-21
62. Li L., He Y., Yang H., Zhu J., Xu X., Dong J., et al. Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. Journal of Clinical Microbiology 43 August (8) (2005) 3835-3839
63. Yang Z., Zhu Q., Li X., Wang X., Wang J., Hu J., et al. Detection of enterovirus 71 and coxsackievirus A16 form children with hand, foot and mouth disease in Shanghai, 2002. Chinese Journal of Pediatrics 43 9 (2005) 648-652
64. Mei Z., Zhang X., Zhao X., and Wang W. The isolation and identification of EV71 isolates in Changchun. Chinese Journal of Laboratory Diagnostics 10 12 (2006) 1515-1516
65. Yang H., He Y., and Feng S. Surveillance of enterovirus type 71 in Shenzhen City in 2002. Chinese Journal of Epidemiology 24 11 (2003) 1015
66. Yang H., He Y., Zhou L., Mao L., Yang F., and Liu J. Surveillance of enterovirus type 71 and coxsackievirus A 16 in Shenzhen in 2004. Chinese Journal of Disease Control & Prevention 10 4 (2006) 389-391
67. He Y., Feng S., Liu K., and Yang H. Surveillance of enterovirus type 71 in Shenzhen in 2001. Disease Surveillance 18 8 (2003) 287
68. He Y., Yang H., Feng S., and Yan Z. Surveillance of enterovirus type 71 in Shenzhen in 2001]. Chinese. Journal of Disease Control and Prevention 7 2 (2003) 153
69. He Y., Yang H., Yan Z., Zhang S., and He J. Surveillance of enterovirus type 71 in Shenzhen in 1999. Chinese Journal of Epidemiology 24 1 (2003) 14
70. Lin T.Y., Twu S.J., Ho M.S., Chang L.Y., and Lee C.Y. Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerging Infectious Diseases 9 March (3) (2003) 291-293
71. Yu C., Chen C., Chen C., Wang J., Liu C., Yan J., et al. Neutralizing antibody provided protection against Enterovirus type 71 lethal challenge in neonatal mice. Journal of Biomedical Science 7 (2000) 523-528
72. Hashimoto I., and Hagiwara A. Pathogenicity of a poliomyelitis-like disease in monkeys infected orally with entervirus 71: a model for human infection. Neuropathology in Applied Neurobiology 8 2 (1982) 149-156
73. Hashimoto I., Hagiwara A., and Kodama H. Neurovirulence in cynomolgus monkeys of entervirus 71 isolated from a patient with hand, foot, and moth disease. Archives of Virology 56 3 (1978) 257-261
74. Ong K.C., Devi S., Cardosa M.J., and Wong K.T. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. Journal of Virology 84 January (1) (2010) 661-665
75. Chung Y.-C., Ho M.-S., Wu J.-C., Chen W.-J., Huang J.-H., Chou S.-T., et al. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 26 15 (2008) 1855-1862
76. Tung W., Bakar S., Sekawi Z., and Rosli R. DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genetic Vaccines and Therapy 5 1 (2007) 6
77. Foo D.G.W., Alonso S., Chow V.T.K., and Poh C.L. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes and Infection 9 11 (2007) 1299-1306
78. Chiu C.-H., Chu C., He C.-C., and Lin T.-Y. Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Microbes and Infection 8 7 (2006) 1671-1678
79. Lin Y.-C., Wu C.-N., Shih S.-R., and Ho M.-S. Characterization of a vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate. Vaccine 20 19-20 (2002) 2485-2493
80. Arita M., Nagata N., Iwata N., Ami Y., Suzaki Y., Mizuta K., et al. An attenuated strain of enterovirus 71 belonging to genotype A showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. Journal of Virology 81 September (17) (2007) 9386-9395
81. Wu S.-C., Liu C.-C., and Lian W.-C. Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development. Vaccine 22 29-30 (2004) 3858-3864
82. Liu C.-C., Lian W.-C., Butler M., and Wu S.-C. High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. Vaccine 25 1 (2007) 19-24
83. Wu C., Lin Y., Cathy Y., Liao N., Shih S., and Ho M. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine 20 (2002) 895-904
84. Chen H.-F., Chang M.-H., Chiang B.-L., and Jeng S.-T. Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine 24 15 (2006) 2944-2951
85. Chen H.-L., Huang J.-Y., Chu T.-W., Tsai T.-C., Hung C.-M., Lin C.-C., et al. Expression of VP1 protein in the milk of transgenic mice: A potential oral vaccine protects against enterovirus 71 infection. Vaccine 26 23 (2008) 2882-2889